分泌性中耳炎患者中耳积液中必需生物膜蛋白的鉴定
本研究收集了38例慢性分泌性中耳炎患儿在鼓膜置管时的中耳积液,用免疫印迹定量检测细菌DNABII家族蛋白IHF和HU。结果显示65%的积液培养阳性,IHF和HU在95%的积液中检出,提示生物膜广泛存在于慢性中耳积液中,DNABII蛋白可作为治疗靶点。
要点
- 慢性分泌性中耳炎患儿中耳积液中普遍存在DNABII家族蛋白IHF和HU,检出率均为95%。
- 65%的积液培养阳性,35%培养阴性,但DNABII蛋白在培养阴性积液中同样检出。
- DNABII蛋白可作为针对生物膜疾病的潜在临床治疗靶点。
核心结论
- DNABII蛋白是细菌生物膜的基本结构成分,其在慢性中耳积液中的普遍存在进一步支持生物膜存在于绝大多数慢性中耳积液中,即使培养阴性。
- DNABII蛋白在分泌性中耳炎标本中的存在和普遍性表明,这些蛋白可作为新型DNABII导向策略治疗生物膜疾病(如慢性分泌性中耳炎)的重要临床靶点。
研究设计与样本
- 研究纳入38例慢性分泌性中耳炎患儿,在鼓膜置管时收集中耳积液。
- 每份标本一部分用于微生物培养,其余材料用免疫印迹定量检测DNABII蛋白IHF和HU。
主要发现
- 65%的积液(24/37)培养出细菌或酵母菌阳性,35%(13/37)培养阴性。
- IHF在95%(36/38)的积液中检出,浓度范围为2至481 ng/μL积液。
- HU在95%(36/38)的积液中检出,定量范围为13至5,264 ng/μL积液(与IHF相比P ≤ 0.05)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Otitis media with effusion (OME) is a common disease of childhood that is largely asymptomatic. However, middle ear fluid can persist for months and negatively impact a child's quality of life. Many cases of OME remain chronic and require surgical intervention. Because biofilms are known to contribute to the persistence of many diseases, this study examined effusions collected from children with chronic OME for the presence of essential biofilm structural components, members of the DNABII family of bacterial DNA-binding proteins. METHODS: Middle ear effusions were recovered from 38 children with chronic OME at the time of tympanostomy tube insertion. A portion of each specimen was submitted for microbiology culture. The remaining material was assessed by immunoblot to quantitate individual DNABII proteins, integration host factor (IHF), and histone-like protein (HU). RESULTS: Sixty-five percent of effusions (24 of 37) were culture-positive for bacterial species or yeast, whereas 35% (13 of 37) were culture-negative. IHF was detected in 95% (36 of 38) at concentrations from 2 to 481 ng/μL effusion. HU was detected in 95% (36 of 38) and quantitated from 13 to 5,264 ng/μL effusion (P ≤ 0.05 compared to IHF). CONCLUSION: Because DNABII proteins are essential structural components of bacterial biofilms, these data lend further support to our understanding that biofilms are present in the vast majority of chronic middle ear effusions, despite negative culture results. The presence and ubiquity of DNABII proteins in OME specimens indicated that these proteins can serve as an important clinical target for our novel DNABII-directed strategy to treat biofilm diseases such as chronic OME. LEVEL OF EVIDENCE: NA Laryngoscope, 130:806-811, 2020.
引用
- Barron CL, Kamel-Abusalha LB, Sethia R, et al. Identification of essential biofilm proteins in middle ear fluids of otitis media with effusion patients. Laryngoscope. 2019. PMID: 31021431. doi:10.1002/lary.28011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。